Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

Cancer Immunology, Immunotherapy

Volumn 51, Issue 4, 2002, Pages 190-199

  Prins, Robert M ^a,b   Scott, Gail P ^a,b   Merchant, Randall E ^a,b   Graf, Martin R ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Adoptive transfer; Glioma; Immunotherapy; Myeloid suppressor cell; T lymphocyte

Indexed keywords

T LYMPHOCYTE RECEPTOR; TUMOR MARKER;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL DENSITY; CELL POPULATION; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GLIOBLASTOMA; GRANULOCYTE; INTRACRANIAL TUMOR; LYMPHOCYTE CLONE; LYMPHOCYTE FUNCTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MODEL; VACCINATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11B; CANCER VACCINES; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; GLIOMA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LYMPHOCYTES, TUMOR-INFILTRATING; RATS; RATS, INBRED F344; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; VACCINATION;

EID: 0036253144     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0270-x     Document Type: Article

References (51)

1. Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
2. Clinical significance of defective dendritic cell differentiation in cancer
3. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes
4. (+) T cells
5. + T cell responses by dysregulating antigen-presenting cell maturation
6. + cells
7. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: Clinical relevance and effects of cytokine therapy
8. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells
9. Sequential development of structural and functional alterations in T cells from tumor-bearing mice
10. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
11. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
12. 2 cytokines and help B cells
13. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma
14. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor
15. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF
16. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
17. (+) myeloid cells
18. + cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells
19. Caspase-mediated degradation of T-cell receptor zeta-chain
20. Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage-colony-stimulating factor
21. Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats
22. IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity
23. Irridiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination
24. Designer dendritic cells for tolerance induction: Guided not misguided missiles
25. + T cell adoptive immunotherapy
26. The instructive role of dendritic cells on T cell responses: Lineages, plasticity and kinetics
27. The JAM test. A simple assay for DNA fragmentation and cell death
28. Antigen-induced unresponsiveness results in altered T cell signaling
29. Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes
30. Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations
31. Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2
32. Treatment of recurrent malignant glioma by repeated intrace-rebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial
33. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
34. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors
35. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in human gliomas with tumor progression
36. (+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor
37. Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis
38. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes
39. Characterization of natural suppressor cells in human bone marrow
40. Brain tumor survival: Results from the National Cancer Data Base
41. Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain
42. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present
43. Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms
44. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses
45. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain
46. + cells from normal bone marrow by Lewis lung carcinoma tumors
47. Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer
48. + natural suppressor cells
49. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide
50. + cells within human head and neck squamous cell carcinomas
51. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression